PBM Price Transparency and Accountability Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 28
- Latest action
- Dec 4, 2025
What it does
The PBM Price Transparency and Accountability Act would amend Medicaid and Medicare provisions to require the Secretary of Health and Human Services to conduct monthly surveys of retail and non-retail pharmacies to establish national average drug acquisition cost benchmarks, with results made publicly available. It would prohibit states from using non-retail pharmacy pricing data to set payments for retail pharmacies, impose civil money penalties of up to $100,000 per violation on pharmacies that fail to comply with survey requirements, and allocate funding for oversight studies by the HHS Inspector General. The bill also aims to prevent abusive spread pricing in Medicaid by requiring…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.